toxCSM: comprehensive prediction of small molecule toxicity profiles.

graph-based signatures machine learning toxCSM toxicity toxicity predictions

Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
20 09 2022
Historique:
received: 19 04 2022
revised: 17 07 2022
accepted: 23 07 2022
pubmed: 24 8 2022
medline: 28 9 2022
entrez: 23 8 2022
Statut: ppublish

Résumé

Drug discovery is a lengthy, costly and high-risk endeavour that is further convoluted by high attrition rates in later development stages. Toxicity has been one of the main causes of failure during clinical trials, increasing drug development time and costs. To facilitate early identification and optimisation of toxicity profiles, several computational tools emerged aiming at improving success rates by timely pre-screening drug candidates. Despite these efforts, there is an increasing demand for platforms capable of assessing both environmental as well as human-based toxicity properties at large scale. Here, we present toxCSM, a comprehensive computational platform for the study and optimisation of toxicity profiles of small molecules. toxCSM leverages on the well-established concepts of graph-based signatures, molecular descriptors and similarity scores to develop 36 models for predicting a range of toxicity properties, which can assist in developing safer drugs and agrochemicals. toxCSM achieved an Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) of up to 0.99 and Pearson's correlation coefficients of up to 0.94 on 10-fold cross-validation, with comparable performance on blind test sets, outperforming all alternative methods. toxCSM is freely available as a user-friendly web server and API at http://biosig.lab.uq.edu.au/toxcsm.

Identifiants

pubmed: 35998885
pii: 6673851
doi: 10.1093/bib/bbac337
pii:
doi:

Substances chimiques

Agrochemicals 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Alex G C de Sá (AGC)

School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane City, Queensland, 4072, Australia.
Systems and Computational Biology, Bio21 Institute, University of Melbourne, Parkville, Victoria, 3052, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.
Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, Victoria, 3010, Australia.

Yangyang Long (Y)

Systems and Computational Biology, Bio21 Institute, University of Melbourne, Parkville, Victoria, 3052, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.
School of Computing and Information Systems, University of Melbourne, Parkville, Victoria, 3052, Australia.

Stephanie Portelli (S)

School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane City, Queensland, 4072, Australia.
Systems and Computational Biology, Bio21 Institute, University of Melbourne, Parkville, Victoria, 3052, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.

Douglas E V Pires (DEV)

Systems and Computational Biology, Bio21 Institute, University of Melbourne, Parkville, Victoria, 3052, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.
School of Computing and Information Systems, University of Melbourne, Parkville, Victoria, 3052, Australia.

David B Ascher (DB)

School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane City, Queensland, 4072, Australia.
Systems and Computational Biology, Bio21 Institute, University of Melbourne, Parkville, Victoria, 3052, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.
Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, Victoria, 3010, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH